1. Home
  2. KRRO vs SOR Comparison

KRRO vs SOR Comparison

Compare KRRO & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • SOR
  • Stock Information
  • Founded
  • KRRO 2014
  • SOR 1968
  • Country
  • KRRO United States
  • SOR United States
  • Employees
  • KRRO N/A
  • SOR N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • SOR Investment Managers
  • Sector
  • KRRO Health Care
  • SOR Finance
  • Exchange
  • KRRO Nasdaq
  • SOR Nasdaq
  • Market Cap
  • KRRO 358.3M
  • SOR 368.0M
  • IPO Year
  • KRRO 2019
  • SOR N/A
  • Fundamental
  • Price
  • KRRO $45.81
  • SOR N/A
  • Analyst Decision
  • KRRO Strong Buy
  • SOR
  • Analyst Count
  • KRRO 7
  • SOR 0
  • Target Price
  • KRRO $96.71
  • SOR N/A
  • AVG Volume (30 Days)
  • KRRO 231.6K
  • SOR 16.2K
  • Earning Date
  • KRRO 11-11-2025
  • SOR 01-01-0001
  • Dividend Yield
  • KRRO N/A
  • SOR 7.24%
  • EPS Growth
  • KRRO N/A
  • SOR N/A
  • EPS
  • KRRO N/A
  • SOR 6.50
  • Revenue
  • KRRO $6,281,000.00
  • SOR N/A
  • Revenue This Year
  • KRRO $116.91
  • SOR N/A
  • Revenue Next Year
  • KRRO N/A
  • SOR N/A
  • P/E Ratio
  • KRRO N/A
  • SOR $6.41
  • Revenue Growth
  • KRRO N/A
  • SOR N/A
  • 52 Week Low
  • KRRO $10.29
  • SOR $36.41
  • 52 Week High
  • KRRO $98.00
  • SOR $42.75
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 66.86
  • SOR N/A
  • Support Level
  • KRRO $43.41
  • SOR N/A
  • Resistance Level
  • KRRO $49.01
  • SOR N/A
  • Average True Range (ATR)
  • KRRO 4.33
  • SOR 0.00
  • MACD
  • KRRO 0.25
  • SOR 0.00
  • Stochastic Oscillator
  • KRRO 77.85
  • SOR 0.00

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About SOR Source Capital Inc.

Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.

Share on Social Networks: